SOURCE: Brighton Markets

November 11, 2011 09:00 ET

Europe Situation Forecasts Change -- Report Highlights NetApp Inc. and Keryx Biopharmaceuticals

NEW YORK, NY--(Marketwire - Nov 11, 2011) - Today, www.BrightonMarkets.com announced new reports highlighting NetApp Inc. (NASDAQ: NTAP) and Keryx Biopharmaceuticals (NASDAQ: KERX). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=NTAP&cob=KERX.

With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% cut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.

Brighton Markets is releasing new coverage on NetApp Inc. for its current position within the technology industry. NetApp Inc. (NetApp) is a provider of storage and data management solutions. The Company has a portfolio of application, virtualization, cloud, and service provider solutions. NetApp's products and services are designed to meet the requirements and service levels of enterprises and their business applications. The full research report on NetApp Inc. (NASDAQ: NTAP) is available here: www.BrightonMarkets.com/index.php?coa=NTAP.

Brighton Markets has released research on Keryx Biopharmaceuticals for its changing role within the healthcare industry. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. The full research report on Keryx Biopharmaceuticals (NASDAQ: KERX) is available here: www.BrightonMarkets.com/index.php?cob=KERX.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information